
Ben Wodicker and Katie Stuart have joined Cyanta Analytical Services as Senior Directors, Business Development. Cyanta, a cGMP contract research organization, offers analytical, bioanalytical and custom synthesis support to the pharmaceutical, biotech and medical device industries. Both team members will promote Cyanta's analytical support services, including characterization, method development and validation, stability services, extractables and leachables testing, medical device testing, and more.
Both Ben Wodicker and Katie Stuart have extensive scientific and laboratory experience. Katie will assist Cyanta clients in the western portions of North America, and Ben will help Cyanta's Midwest and East Coast clientele. "We are pleased to have both Ben and Katie on board," says David W. Riggs PE, President, Cyanta Analytical Services. "Their knowledge of cGMPs and understanding of the drug development process will play a key role in communicating Cyanta's broad range of analytical, bioanalytical and custom synthesis services."

